SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TLT.v -- Ignore unavailable to you. Want to Upgrade?


To: ogi who wrote (1413)11/8/2019 10:23:08 PM
From: Underexposed  Read Replies (2) | Respond to of 1631
 
The fact TLT's 2000 series lasers have been recalled by Health Canada and not a word said by the company just reeks. Pretty hard not to draw a connection between that fact and the departure of the new CEO of devices division.

Yeah, you are probably right...in reading the recall by health Canada it looks like a cluster-F for delivery. They have been making that TLC-2000 for years.... has this been a problem all along or did they jump the gun .... hard to say.

I don't think this affects the Phase II study at all as a different laser is being used.
That said, it is hard to believe recruitment is so slow in Canada , while the U.S. sites have not been brought onboard yet.
It is not unlike last time.... they have a very specific criteria that has to be met. I am encouraged that they at least have one candidate as of September and that Patient 6 and 5 are cancer free still.

I think they have an order to this trial... first Canadian sites.... 3 selected now.... then USA.... then Europe.

It is my guess they want to make any mistakes in this phase in Canada rather than shotgun it out immediately .... that is my guess anyway.

UE